Mellitus
Boston, US · Founded 2011 · Delaware LLC · 2 known investors
Biotech
Founders & leadership
Mellitus was founded in 2011 by Jose Halperin.
JH
Jose HalperinFounder
JL
Joyce LonerganExecutive
MC
Michael ChorevNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$15.7M disclosed across 10 rounds · 2015–2023
▶$90KraisedAug 2023 · 2 investors · BiotechnologyRule 506(b)
▶$90KraisedAug 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gail PageDirector
- Edwin Henrie, IIDirector
- John TagliamonteExecutive Officer, Director
- Jose HalperinDirector
- Michael ChorevDirector
- Christopher de SouzaDirector
- Offering amount
- $750K
- Amount sold
- $90K
- First sale
- Aug 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.8MraisedMay 2019 · 11 investors · Other Health CareRule 506(b)
▶$2.8MraisedMay 2019 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joyce A. LonerganExecutive Officer, Director
- Michael ChorevDirector
- Jose HalperinDirector
- Ellie McGuireDirector
- Christopher de SouzaDirector
- Xing ZhaoDirector
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- First sale
- Apr 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedOct 2018 · 6 investors · BiotechnologyRule 506(b)
▶$1.7MraisedOct 2018 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael ChorevDirector
- Ellie McGuireDirector
- Christopher de SouzaDirector
- Joyce A. LonerganExecutive Officer, Director
- Jose HalperinDirector
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- First sale
- Sep 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedAug 2018 · 2 investors · BiotechnologyRule 506(b)
▶$1.7MraisedAug 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joyce A. LonerganExecutive Officer, Director
- Michael ChorevDirector
- Ellie McGuireDirector
- Jose HalperinDirector
- Christopher de SouzaDirector
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- First sale
- Jul 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedMay 2018 · 39 investors · BiotechnologyRule 506(b)
▶$5.6MraisedMay 2018 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jose HalperinDirector
- Michael ChorevDirector
- Joyce A. LonerganExecutive Officer, Director
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- First sale
- Apr 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedMay 2017 · 26 investors · BiotechnologyRule 506(b)
▶$2.1MraisedMay 2017 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael ChorevDirector
- Jose HalperinDirector
- Joyce A. LonerganExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.1M
- First sale
- Feb 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$992.9KraisedMay 2016 · 25 investors · BiotechnologyRule 506(c)
▶$992.9KraisedMay 2016 · 25 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Jose HalperinDirector
- Michael ChorevDirector
- Joyce A. LonerganExecutive Officer
- Offering amount
- $1M
- Amount sold
- $992.9K
- First sale
- May 2016
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06c
▶$50KraisedJan 2016 · 3 investors · BiotechnologyRule 506(b)
▶$50KraisedJan 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael ChorevDirector
- Jose HalperinDirector
- Joyce LonerganExecutive Officer
- Offering amount
- $50K
- Amount sold
- $50K
- First sale
- Dec 2015
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.6M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Mellitus?
- Mellitus was founded by Jose Halperin in 2011.
- Who are Mellitus's investors?
- Mellitus's investors include Dreamers VC, Elephant Partners.
- How much funding has Mellitus raised?
- Mellitus has disclosed $15.7M raised across 10 rounds.
- Where is Mellitus headquartered?
- Mellitus is headquartered in Boston, US.